Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma

Insulinomas are rare tumors, and approximately 10% of insulinomas are malignant. Accumulating evidence has implicated that we still lack effective therapy to treat the patients who are diagnosed with rare malignant insulinoma. Previous studies have reported that Andrographolide (Andro) could inhibit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhang, Qian-Qian, Ding, Yi, Lei, Yan, Qi, Cui-Ling, He, Xiao-Dong, Lan, Tian, Li, Jiang-Chao, Gong, Ping, Yang, Xuesong, Geng, Jian-Guo, Wang, Li-Jing
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3979993/
https://ncbi.nlm.nih.gov/pubmed/24719558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.7723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados